Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports

Anthropic has finalized the acquisition of Coefficient Bio, an AI-driven biotech startup, in a deal valued at $400 million, according to industry reports. This acquisition comes as Anthropic expands deeper into healthcare and life sciences, following its introduction of Claude for Life Sciences just months before—an AI tool designed to accelerate scientific breakthroughs.

About Coefficient Bio

Cofounded by Samuel Stanton and Nathan C. Frey—both veterans of Genentech’s Prescient Design—Coefficient Bio was established eight months ago. The company focuses on leveraging artificial intelligence for drug discovery and enhancing the efficiency of biological research processes.

What This Means for Anthropic

The Coefficient Bio team, comprised of approximately 10 specialists, is expected to join Anthropic’s health and life sciences division. This strategic acquisition reflects Anthropic's ongoing commitment to applying advanced AI technologies in scientific and medical domains.

For more details, visit the original TechCrunch article.